nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—cervical cancer	0.762	1	CbGaD
Acetylsalicylic acid—TP53—exocrine gland—cervical cancer	0.00507	0.0424	CbGeAlD
Acetylsalicylic acid—NFKBIA—exocrine gland—cervical cancer	0.00499	0.0417	CbGeAlD
Acetylsalicylic acid—HSPA5—exocrine gland—cervical cancer	0.00488	0.0409	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—cervical cancer	0.00221	0.0185	CbGeAlD
Acetylsalicylic acid—TP53—uterine cervix—cervical cancer	0.00219	0.0183	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—cervical cancer	0.00217	0.0182	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterine cervix—cervical cancer	0.00215	0.018	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—cervical cancer	0.00213	0.0178	CbGeAlD
Acetylsalicylic acid—HSPA5—uterine cervix—cervical cancer	0.00211	0.0176	CbGeAlD
Acetylsalicylic acid—TP53—decidua—cervical cancer	0.00208	0.0174	CbGeAlD
Acetylsalicylic acid—NFKBIA—decidua—cervical cancer	0.00205	0.0172	CbGeAlD
Acetylsalicylic acid—TP53—renal system—cervical cancer	0.00205	0.0171	CbGeAlD
Acetylsalicylic acid—NFKBIA—renal system—cervical cancer	0.00201	0.0168	CbGeAlD
Acetylsalicylic acid—HSPA5—decidua—cervical cancer	0.00201	0.0168	CbGeAlD
Acetylsalicylic acid—TP53—endometrium—cervical cancer	0.00198	0.0166	CbGeAlD
Acetylsalicylic acid—HSPA5—renal system—cervical cancer	0.00197	0.0165	CbGeAlD
Acetylsalicylic acid—NFKBIA—endometrium—cervical cancer	0.00195	0.0163	CbGeAlD
Acetylsalicylic acid—TP53—mammalian vulva—cervical cancer	0.00191	0.016	CbGeAlD
Acetylsalicylic acid—HSPA5—endometrium—cervical cancer	0.00191	0.0159	CbGeAlD
Acetylsalicylic acid—NFKBIA—mammalian vulva—cervical cancer	0.00188	0.0158	CbGeAlD
Acetylsalicylic acid—HSPA5—mammalian vulva—cervical cancer	0.00184	0.0154	CbGeAlD
Acetylsalicylic acid—TP53—uterus—cervical cancer	0.00182	0.0153	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterine cervix—cervical cancer	0.00179	0.015	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—cervical cancer	0.00179	0.015	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—cervical cancer	0.00176	0.0147	CbGeAlD
Acetylsalicylic acid—RPS6KA3—decidua—cervical cancer	0.00171	0.0143	CbGeAlD
Acetylsalicylic acid—RPS6KA3—renal system—cervical cancer	0.00168	0.014	CbGeAlD
Acetylsalicylic acid—TP53—female reproductive system—cervical cancer	0.00164	0.0137	CbGeAlD
Acetylsalicylic acid—RPS6KA3—endometrium—cervical cancer	0.00162	0.0136	CbGeAlD
Acetylsalicylic acid—NFKBIA—female reproductive system—cervical cancer	0.00161	0.0135	CbGeAlD
Acetylsalicylic acid—HSPA5—female reproductive system—cervical cancer	0.00158	0.0132	CbGeAlD
Acetylsalicylic acid—RPS6KA3—mammalian vulva—cervical cancer	0.00157	0.0131	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterus—cervical cancer	0.0015	0.0125	CbGeAlD
Acetylsalicylic acid—TP53—female gonad—cervical cancer	0.00149	0.0125	CbGeAlD
Acetylsalicylic acid—TP53—vagina—cervical cancer	0.00148	0.0124	CbGeAlD
Acetylsalicylic acid—NFKBIA—female gonad—cervical cancer	0.00147	0.0123	CbGeAlD
Acetylsalicylic acid—EDNRA—uterine cervix—cervical cancer	0.00146	0.0122	CbGeAlD
Acetylsalicylic acid—NFKBIA—vagina—cervical cancer	0.00146	0.0122	CbGeAlD
Acetylsalicylic acid—HSPA5—female gonad—cervical cancer	0.00144	0.012	CbGeAlD
Acetylsalicylic acid—HSPA5—vagina—cervical cancer	0.00143	0.0119	CbGeAlD
Acetylsalicylic acid—EDNRA—decidua—cervical cancer	0.00139	0.0116	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female reproductive system—cervical cancer	0.00134	0.0113	CbGeAlD
Acetylsalicylic acid—IKBKB—uterine cervix—cervical cancer	0.00132	0.0111	CbGeAlD
Acetylsalicylic acid—EDNRA—endometrium—cervical cancer	0.00132	0.011	CbGeAlD
Acetylsalicylic acid—EDNRA—mammalian vulva—cervical cancer	0.00128	0.0107	CbGeAlD
Acetylsalicylic acid—IKBKB—decidua—cervical cancer	0.00126	0.0106	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female gonad—cervical cancer	0.00122	0.0102	CbGeAlD
Acetylsalicylic acid—RPS6KA3—vagina—cervical cancer	0.00122	0.0102	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—cervical cancer	0.00122	0.0102	CbGeAlD
Acetylsalicylic acid—SLC22A7—renal system—cervical cancer	0.0012	0.0101	CbGeAlD
Acetylsalicylic acid—IKBKB—endometrium—cervical cancer	0.0012	0.01	CbGeAlD
Acetylsalicylic acid—IKBKB—mammalian vulva—cervical cancer	0.00116	0.0097	CbGeAlD
Acetylsalicylic acid—IKBKB—uterus—cervical cancer	0.0011	0.00924	CbGeAlD
Acetylsalicylic acid—EDNRA—female gonad—cervical cancer	0.000995	0.00832	CbGeAlD
Acetylsalicylic acid—IKBKB—female reproductive system—cervical cancer	0.000993	0.00831	CbGeAlD
Acetylsalicylic acid—EDNRA—vagina—cervical cancer	0.000989	0.00827	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—cervical cancer	0.000958	0.00802	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—cervical cancer	0.000943	0.00789	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—cervical cancer	0.000923	0.00773	CbGeAlD
Acetylsalicylic acid—IKBKB—female gonad—cervical cancer	0.000903	0.00756	CbGeAlD
Acetylsalicylic acid—IKBKB—vagina—cervical cancer	0.000898	0.00751	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—cervical cancer	0.000787	0.00658	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—cervical cancer	0.000639	0.00535	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—cervical cancer	0.000581	0.00486	CbGeAlD
Acetylsalicylic acid—CYP2C8—renal system—cervical cancer	0.000508	0.00425	CbGeAlD
Acetylsalicylic acid—CYP2C8—endometrium—cervical cancer	0.000492	0.00411	CbGeAlD
Acetylsalicylic acid—PTGS1—epithelium—cervical cancer	0.000445	0.00372	CbGeAlD
Acetylsalicylic acid—PTGS1—uterine cervix—cervical cancer	0.000441	0.00369	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—cervical cancer	0.000425	0.00356	CbGeAlD
Acetylsalicylic acid—CYP2C19—vagina—cervical cancer	0.000422	0.00353	CbGeAlD
Acetylsalicylic acid—PTGS2—uterine cervix—cervical cancer	0.000421	0.00353	CbGeAlD
Acetylsalicylic acid—PTGS1—renal system—cervical cancer	0.000412	0.00345	CbGeAlD
Acetylsalicylic acid—CYP2C8—female reproductive system—cervical cancer	0.000407	0.00341	CbGeAlD
Acetylsalicylic acid—PTGS1—endometrium—cervical cancer	0.000399	0.00334	CbGeAlD
Acetylsalicylic acid—PTGS2—renal system—cervical cancer	0.000394	0.0033	CbGeAlD
Acetylsalicylic acid—PTGS1—mammalian vulva—cervical cancer	0.000386	0.00323	CbGeAlD
Acetylsalicylic acid—PTGS2—endometrium—cervical cancer	0.000381	0.00319	CbGeAlD
Acetylsalicylic acid—CYP2C8—vagina—cervical cancer	0.000368	0.00308	CbGeAlD
Acetylsalicylic acid—PTGS1—uterus—cervical cancer	0.000367	0.00307	CbGeAlD
Acetylsalicylic acid—CYP2C9—female reproductive system—cervical cancer	0.000362	0.00303	CbGeAlD
Acetylsalicylic acid—PTGS2—uterus—cervical cancer	0.000351	0.00294	CbGeAlD
Acetylsalicylic acid—ALB—lymph node—cervical cancer	0.000339	0.00284	CbGeAlD
Acetylsalicylic acid—PTGS1—female reproductive system—cervical cancer	0.00033	0.00276	CbGeAlD
Acetylsalicylic acid—PTGS2—female reproductive system—cervical cancer	0.000316	0.00264	CbGeAlD
Acetylsalicylic acid—PTGS1—female gonad—cervical cancer	0.0003	0.00251	CbGeAlD
Acetylsalicylic acid—PTGS1—vagina—cervical cancer	0.000299	0.0025	CbGeAlD
Acetylsalicylic acid—PTGS2—female gonad—cervical cancer	0.000287	0.0024	CbGeAlD
Acetylsalicylic acid—PTGS2—vagina—cervical cancer	0.000285	0.00239	CbGeAlD
Acetylsalicylic acid—ABCB1—epithelium—cervical cancer	0.000263	0.0022	CbGeAlD
Acetylsalicylic acid—ABCB1—uterine cervix—cervical cancer	0.000261	0.00218	CbGeAlD
Acetylsalicylic acid—ABCB1—decidua—cervical cancer	0.000248	0.00208	CbGeAlD
Acetylsalicylic acid—ABCB1—renal system—cervical cancer	0.000244	0.00204	CbGeAlD
Acetylsalicylic acid—ABCB1—endometrium—cervical cancer	0.000236	0.00197	CbGeAlD
Acetylsalicylic acid—ABCB1—mammalian vulva—cervical cancer	0.000228	0.00191	CbGeAlD
Acetylsalicylic acid—ABCB1—uterus—cervical cancer	0.000217	0.00182	CbGeAlD
Acetylsalicylic acid—ABCB1—female reproductive system—cervical cancer	0.000195	0.00163	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—cervical cancer	0.000193	0.00162	CbGeAlD
Acetylsalicylic acid—PTGS2—lymph node—cervical cancer	0.000185	0.00155	CbGeAlD
Acetylsalicylic acid—ABCB1—female gonad—cervical cancer	0.000178	0.00149	CbGeAlD
Acetylsalicylic acid—ABCB1—vagina—cervical cancer	0.000177	0.00148	CbGeAlD
Acetylsalicylic acid—ABCB1—lymph node—cervical cancer	0.000114	0.000956	CbGeAlD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—WNT5A—cervical cancer	8.02e-05	0.000678	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—CASP3—cervical cancer	8e-05	0.000676	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—FGFR3—cervical cancer	8e-05	0.000676	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—p75(NTR)-mediated signaling—TP53—cervical cancer	7.96e-05	0.000673	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	7.94e-05	0.000671	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.93e-05	0.00067	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—STAT3—cervical cancer	7.93e-05	0.00067	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—FGFR3—cervical cancer	7.89e-05	0.000667	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TP53—cervical cancer	7.85e-05	0.000664	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DPB1—cervical cancer	7.71e-05	0.000651	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	7.68e-05	0.000649	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	7.68e-05	0.000649	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—FGFR3—cervical cancer	7.58e-05	0.00064	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—WNT2—cervical cancer	7.57e-05	0.00064	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—WNT2—cervical cancer	7.57e-05	0.00064	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—STAT3—cervical cancer	7.52e-05	0.000636	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	7.52e-05	0.000635	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—NOTCH1—cervical cancer	7.5e-05	0.000634	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—MTOR—cervical cancer	7.49e-05	0.000633	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—CTNNB1—cervical cancer	7.49e-05	0.000633	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKAP13—cervical cancer	7.44e-05	0.000629	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKAP13—cervical cancer	7.35e-05	0.000621	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—STAT3—cervical cancer	7.29e-05	0.000616	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—TP53—cervical cancer	7.24e-05	0.000612	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—STAT3—cervical cancer	7.17e-05	0.000606	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—FGFR3—cervical cancer	7.05e-05	0.000596	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—CASP3—cervical cancer	6.89e-05	0.000582	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DPB1—cervical cancer	6.89e-05	0.000582	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—MTOR—cervical cancer	6.88e-05	0.000582	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CASP8—cervical cancer	6.84e-05	0.000578	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—EGFR—cervical cancer	6.83e-05	0.000578	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—CASP8—cervical cancer	6.82e-05	0.000576	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TP53—cervical cancer	6.8e-05	0.000575	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CASP8—cervical cancer	6.75e-05	0.00057	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—STAT3—cervical cancer	6.72e-05	0.000568	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	6.65e-05	0.000562	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKAP13—cervical cancer	6.65e-05	0.000562	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKAP13—cervical cancer	6.65e-05	0.000562	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—CTNNB1—cervical cancer	6.64e-05	0.000561	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HES1—cervical cancer	6.59e-05	0.000557	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—EGFR—cervical cancer	6.52e-05	0.000551	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—WNT5A—cervical cancer	6.42e-05	0.000543	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—TP53—cervical cancer	6.38e-05	0.000539	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	6.35e-05	0.000537	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—WNT5A—cervical cancer	6.35e-05	0.000536	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—TP53—cervical cancer	6.33e-05	0.000535	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—FGFR3—cervical cancer	6.15e-05	0.00052	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—EGFR—cervical cancer	6.11e-05	0.000516	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—CASP3—cervical cancer	6.09e-05	0.000515	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CASP8—cervical cancer	6.03e-05	0.00051	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DQB1—cervical cancer	6.02e-05	0.000508	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—MTOR—cervical cancer	5.88e-05	0.000497	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MTHFR—cervical cancer	5.79e-05	0.000489	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—STAT3—cervical cancer	5.79e-05	0.000489	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TERT—cervical cancer	5.77e-05	0.000488	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—WNT5A—cervical cancer	5.74e-05	0.000485	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—WNT5A—cervical cancer	5.74e-05	0.000485	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—UBE3A—cervical cancer	5.74e-05	0.000485	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DPB1—cervical cancer	5.65e-05	0.000477	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOTCH2—cervical cancer	5.63e-05	0.000476	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—MTOR—cervical cancer	5.63e-05	0.000476	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD8A—cervical cancer	5.62e-05	0.000475	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CD4—cervical cancer	5.62e-05	0.000475	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—MTOR—cervical cancer	5.55e-05	0.000469	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CD4—cervical cancer	5.54e-05	0.000468	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—EGFR—cervical cancer	5.53e-05	0.000467	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—TP53—cervical cancer	5.47e-05	0.000462	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DQB1—cervical cancer	5.38e-05	0.000455	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—MTOR—cervical cancer	5.33e-05	0.00045	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—CD4—cervical cancer	5.32e-05	0.00045	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—FGFR3—cervical cancer	5.3e-05	0.000448	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	5.28e-05	0.000446	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—CASP3—cervical cancer	5.16e-05	0.000436	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD8A—cervical cancer	5.02e-05	0.000424	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CTNNB1—cervical cancer	4.99e-05	0.000422	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—CTNNB1—cervical cancer	4.98e-05	0.000421	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NOTCH1—cervical cancer	4.98e-05	0.00042	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—MTOR—cervical cancer	4.96e-05	0.000419	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CD4—cervical cancer	4.95e-05	0.000419	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CTNNB1—cervical cancer	4.92e-05	0.000416	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—MTHFR—cervical cancer	4.85e-05	0.00041	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TAAR6—cervical cancer	4.82e-05	0.000408	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	4.74e-05	0.000401	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—cervical cancer	4.67e-05	0.000395	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—EGFR—cervical cancer	4.65e-05	0.000393	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HES1—cervical cancer	4.61e-05	0.00039	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—FGFR3—cervical cancer	4.6e-05	0.000388	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOTCH2—cervical cancer	4.51e-05	0.000381	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	4.46e-05	0.000377	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOTCH2—cervical cancer	4.45e-05	0.000376	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DQB1—cervical cancer	4.41e-05	0.000373	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CTNNB1—cervical cancer	4.4e-05	0.000372	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—cervical cancer	4.36e-05	0.000368	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—STAT3—cervical cancer	4.35e-05	0.000368	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—STAT3—cervical cancer	4.34e-05	0.000367	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—MTOR—cervical cancer	4.33e-05	0.000366	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—EGFR—cervical cancer	4.13e-05	0.000349	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD8A—cervical cancer	4.12e-05	0.000348	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—FGFR3—cervical cancer	4.11e-05	0.000347	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TERT—cervical cancer	4.04e-05	0.000342	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	4.03e-05	0.000341	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOTCH2—cervical cancer	4.03e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOTCH2—cervical cancer	4.03e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—CASP3—cervical cancer	3.98e-05	0.000336	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—EGFR—cervical cancer	3.95e-05	0.000334	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—EGFR—cervical cancer	3.95e-05	0.000333	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CASP8—cervical cancer	3.93e-05	0.000332	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—cervical cancer	3.9e-05	0.00033	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—EGFR—cervical cancer	3.9e-05	0.000329	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—WNT2—cervical cancer	3.77e-05	0.000318	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—EGFR—cervical cancer	3.74e-05	0.000316	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MTOR—cervical cancer	3.73e-05	0.000315	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CD4—cervical cancer	3.72e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—FGFR3—cervical cancer	3.71e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HES1—cervical cancer	3.69e-05	0.000312	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HES1—cervical cancer	3.65e-05	0.000309	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.59e-05	0.000303	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—WNT2—cervical cancer	3.51e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CASP8—cervical cancer	3.51e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—FGFR3—cervical cancer	3.51e-05	0.000296	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CA9—cervical cancer	3.5e-05	0.000296	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—EGFR—cervical cancer	3.48e-05	0.000295	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOTCH1—cervical cancer	3.48e-05	0.000294	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	3.46e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DPB1—cervical cancer	3.43e-05	0.00029	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—STAT3—cervical cancer	3.4e-05	0.000287	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—cervical cancer	3.38e-05	0.000286	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—FGFR3—cervical cancer	3.37e-05	0.000285	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	3.36e-05	0.000284	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—STAT3—cervical cancer	3.34e-05	0.000283	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKAP13—cervical cancer	3.31e-05	0.000279	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CTNNB1—cervical cancer	3.31e-05	0.000279	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HES1—cervical cancer	3.3e-05	0.000279	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HES1—cervical cancer	3.3e-05	0.000279	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TERT—cervical cancer	3.24e-05	0.000274	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—MTOR—cervical cancer	3.23e-05	0.000273	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD4—cervical cancer	3.23e-05	0.000273	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TERT—cervical cancer	3.2e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—cervical cancer	3.04e-05	0.000257	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CASP8—cervical cancer	3e-05	0.000253	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—FGFR3—cervical cancer	2.97e-05	0.000251	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—FGFR3—cervical cancer	2.94e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TERT—cervical cancer	2.89e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TERT—cervical cancer	2.89e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—MTOR—cervical cancer	2.89e-05	0.000244	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—cervical cancer	2.88e-05	0.000244	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—STAT3—cervical cancer	2.88e-05	0.000243	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CTNNB1—cervical cancer	2.87e-05	0.000242	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—WNT5A—cervical cancer	2.85e-05	0.000241	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOTCH1—cervical cancer	2.79e-05	0.000236	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CA9—cervical cancer	2.78e-05	0.000235	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOTCH1—cervical cancer	2.76e-05	0.000233	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	2.74e-05	0.000232	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQB1—cervical cancer	2.67e-05	0.000226	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—WNT5A—cervical cancer	2.66e-05	0.000225	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—FGFR3—cervical cancer	2.66e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—FGFR3—cervical cancer	2.66e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—cervical cancer	2.62e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MTOR—cervical cancer	2.61e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CTNNB1—cervical cancer	2.56e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	2.55e-05	0.000215	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—STAT3—cervical cancer	2.5e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—cervical cancer	2.5e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOTCH1—cervical cancer	2.49e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOTCH1—cervical cancer	2.49e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MTOR—cervical cancer	2.47e-05	0.000209	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—cervical cancer	2.46e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	2.45e-05	0.000207	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CASP3—cervical cancer	2.4e-05	0.000203	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—MTOR—cervical cancer	2.37e-05	0.0002	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—cervical cancer	2.37e-05	0.0002	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CTNNB1—cervical cancer	2.31e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.3e-05	0.000195	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—cervical cancer	2.27e-05	0.000192	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CA9—cervical cancer	2.26e-05	0.000191	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CA9—cervical cancer	2.25e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—STAT3—cervical cancer	2.23e-05	0.000189	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—cervical cancer	2.22e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—cervical cancer	2.22e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CTNNB1—cervical cancer	2.19e-05	0.000185	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MTOR—cervical cancer	2.09e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MTOR—cervical cancer	2.07e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FGFR3—cervical cancer	2.04e-05	0.000173	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—cervical cancer	2.03e-05	0.000172	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CA9—cervical cancer	2.02e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STAT3—cervical cancer	2.02e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOTCH2—cervical cancer	2e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CA9—cervical cancer	1.97e-05	0.000166	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.94e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP3—cervical cancer	1.92e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP3—cervical cancer	1.9e-05	0.000161	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MTOR—cervical cancer	1.87e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MTOR—cervical cancer	1.87e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CTNNB1—cervical cancer	1.85e-05	0.000157	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CA9—cervical cancer	1.84e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—cervical cancer	1.83e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CTNNB1—cervical cancer	1.83e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CASP8—cervical cancer	1.75e-05	0.000148	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—cervical cancer	1.73e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP3—cervical cancer	1.72e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP3—cervical cancer	1.72e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—cervical cancer	1.66e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CTNNB1—cervical cancer	1.66e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CTNNB1—cervical cancer	1.66e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HES1—cervical cancer	1.64e-05	0.000139	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.63e-05	0.000138	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STAT3—cervical cancer	1.62e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STAT3—cervical cancer	1.6e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—cervical cancer	1.54e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HES1—cervical cancer	1.53e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—cervical cancer	1.47e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—cervical cancer	1.45e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—cervical cancer	1.44e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—cervical cancer	1.44e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TERT—cervical cancer	1.44e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MTOR—cervical cancer	1.44e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—cervical cancer	1.43e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MTHFR—cervical cancer	1.42e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTHFR—cervical cancer	1.35e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TERT—cervical cancer	1.34e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGFR3—cervical cancer	1.32e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—cervical cancer	1.31e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—cervical cancer	1.31e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—cervical cancer	1.27e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOTCH1—cervical cancer	1.24e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—cervical cancer	1.23e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGFR3—cervical cancer	1.23e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOTCH1—cervical cancer	1.16e-05	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—cervical cancer	1.13e-05	9.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—cervical cancer	1.11e-05	9.39e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—cervical cancer	1.1e-05	9.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—cervical cancer	1.1e-05	9.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—cervical cancer	1.01e-05	8.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—cervical cancer	9.29e-06	7.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—cervical cancer	9.17e-06	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—cervical cancer	9.12e-06	7.71e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—cervical cancer	8.67e-06	7.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—cervical cancer	8.65e-06	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—cervical cancer	8.55e-06	7.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—cervical cancer	8.54e-06	7.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—cervical cancer	8.24e-06	6.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—cervical cancer	8.19e-06	6.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—cervical cancer	7.99e-06	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—cervical cancer	7.68e-06	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—cervical cancer	7.47e-06	6.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—cervical cancer	7.18e-06	6.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—cervical cancer	6.7e-06	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—cervical cancer	6.53e-06	5.52e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—cervical cancer	6.09e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—cervical cancer	5.48e-06	4.63e-05	CbGpPWpGaD
